Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was...
Exercise provided considerable weight loss-independent benefits in patients with nonalcoholic fatty liver disease, according to research published in JHEP Reports....
Nurses in the United States had a significantly increased risk for suicide compared with the general population, according to results of a retrospective cohort...
Four out of five top stories in infectious disease last week were about updates on COVID-19 vaccination.
More than 40% of U.S. military veterans reported moderate or greater levels of posttraumatic growth linked to the COVID-19 pandemic, according to results of a survey...
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world...
Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial...
Tempus announced the FDA has granted a breakthrough device designation to its ECG analysis platform for the identification of atrial fibrillation or atrial flutter,...
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were...
Hospitals in the highest tier of case volume may offer better outcomes for patients undergoing surgery for gastrointestinal cancers, according to study results.